Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'dopamine receptor' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2305 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Javitch, JA; Shi, L; Liapakis, G
      Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors

      G PROTEIN PATHWAYS, PT A, RECEPTORS
    2. Visiers, I; Ballesteros, JA; Weinstein, H
      Three-dimensional representations of G protein-coupled receptor structuresand mechanisms

      G PROTEIN PATHWAYS, PT A, RECEPTORS
    3. Kapp, OH; Siemion, J; Kuo, J; Johnson, BA; Shankaran, V; Reba, RC; Mukherjee, J
      Comparison of the interaction of dopamine and high affinity positron emission tomography radiotracer fallypride with the dopamine D-2 receptor: a molecular modeling study

      JOURNAL OF MOLECULAR MODELING
    4. Berlind, A
      Effects of haloperidol and phentolamine on the crustacean cardiac ganglion

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    5. Berlind, A
      Monoamine pharmacology of the lobster cardiac ganglion

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
    6. Ito, Y; Horie, S; Shindo, Y
      A novel [2+2] photodimerization of N-[(E)-3,4-methylenedioxycinnamoyl]dopamine in the solid state

      ORGANIC LETTERS
    7. Walton, R; Johnstone, E; Munafo, M; Neville, M; Griffiths, S
      Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy

      TRENDS IN MOLECULAR MEDICINE
    8. Gimenez-Llort, L; Ahlbom, E; Dare, E; Vahter, M; Ogren, SO; Ceccatelli, S
      Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects

      ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    9. Roth-Harer, A; Lilienthal, H; Bubser, M; Kronthaler, U; Mundy, WR; Ward, TR; Schmidt, W; Winterhoff, H; Winneke, G
      Neurotransmitter concentrations and binding at dopamine receptors in rats after maternal exposure to 3,4,3 ',4 '-tetrachlorobiphenyl: the role of reduced thyroid hormone concentrations

      ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    10. Ekelund, J; Suhonen, J; Jarvelin, MR; Peltonen, L; Lichtermann, D
      No association of the-521 C/T polymorphism in the promoter of DRD4 with novelty seeking

      MOLECULAR PSYCHIATRY
    11. Rowe, DC; Stever, C; Chase, D; Sherman, S; Abramowitz, A; Waldman, ID
      Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms

      MOLECULAR PSYCHIATRY
    12. Mirnics, K; Middleton, FA; Stanwood, GD; Lewis, DA; Levitt, P
      Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

      MOLECULAR PSYCHIATRY
    13. Segman, RH; Heresco-Levy, U; Finkel, B; Goltser, T; Shalem, R; Schlafman, M; Dorevitch, A; Yakir, A; Greenberg, D; Lerner, A; Lerer, B
      Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia

      MOLECULAR PSYCHIATRY
    14. Basile, VS; Ozdemir, V; Masellis, M; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, FM; Petronis, A; Kennedy, JL
      Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    15. Bau, CHD; Almeida, S; Costa, FT; Garcia, CED; Elias, EP; Ponso, AC; Spode, A; Hutz, MH
      DRD4 and DAT1 as modifying genes in alcoholism: interaction with novelty seeking on level of alcohol consumption

      MOLECULAR PSYCHIATRY
    16. Ronai, Z; Szekely, A; Nemoda, Z; Lakatos, K; Gervai, J; Staub, M; Sasvari-Szekely, M
      Association between Novelty Seeking and the-521 C/T polymorphism in the promoter region of the DRD4 gene

      MOLECULAR PSYCHIATRY
    17. Lee, D; Wang, L; Dong, P; Tran, T; Copolov, D; Lim, AT
      Progesterone modulation of D5 receptor expression in hypothalamic ANP neurons, the role of estrogen

      MOLECULAR PSYCHIATRY
    18. Joyce, JN; Ryoo, H; Gurevich, EV; Adler, C; Beach, T
      Ventral striatal D-3 receptors and Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    19. Guttman, M; Jaskolka, J
      The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?

      PARKINSONISM & RELATED DISORDERS
    20. Okura, M; Fujiki, N; Ripley, B; Takahashi, S; Amitai, N; Mignot, E; Nishino, S
      Narcoleptic canines display periodic leg movements during sleep

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    21. Li, D; Chokka, P; Tibbo, P
      Toward an integrative understanding of social phobia

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    22. Arranz, MJ; Mancama, D; Kerwin, RW
      Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    23. Chandhoke, V; Southall, M; Holt, R; Flinn, JM
      Dopamine receptor subtype density as a function of age in Aplysia californica

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
    24. Alexopoulos, GS
      "The depression-executive dysfunction syndrome of late life" - A specific target for D-3 agonists?

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    25. Hussain, T; Becker, M; Beheray, S; Lokhandwala, MF
      Dopamine fails to inhibit Na,H-exchanger in proximal tubules of obese Zucker rats

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    26. Zimprich, A; Grabowski, M; Asmus, F; Naumann, M; Berg, D; Bertram, M; Scheidtmann, K; Kern, P; Winkelmann, F; Muller-Myhsok, B; Riedel, L; Bauer, M; Muller, T; Castro, M; Meitinger, T; Strom, TM; Gasser, T
      Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome

      NATURE GENETICS
    27. Avalos, M; Mak, C; Randall, PK; Trzeciakowski, JP; Abell, C; Kwan, SW; Wilcox, RE
      Nonlinear analysis of partial dopamine agonist effects on cAMP in C6 glioma cells

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    28. Botteron, KN
      Genetic analysis of brain imaging abnormalities

      CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA
    29. Richtand, NM; Goldsmith, RJ; Nolan, JE; Berger, SP
      The D3 dopamine receptor and substance dependence

      JOURNAL OF ADDICTIVE DISEASES
    30. Malcolm, R; Herron, J; Sutherland, SE; Brady, KT
      Adverse outcomes in a controlled trial of pergolide for cocaine dependence

      JOURNAL OF ADDICTIVE DISEASES
    31. Suhara, T; Yasuno, F; Sudo, Y; Yamamoto, M; Inoue, M; Okubo, Y; Suzuki, K
      Dopamine D2 receptors in the insular cortex and the personality trait of novelty seeking

      NEUROIMAGE
    32. Shen, DHY; Kloos, RT; Mazzaferri, EL; Jhiang, SM
      Sodium iodide symporter in health and disease

      THYROID
    33. Spencer, T; Biederman, J; Heiligenstein, J; Wilens, T; Faries, D; Prince, J; Faraone, SV; Rea, J; Witcher, J; Zervas, S
      An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    34. Woo, SH; Kim, HS; Yun, JS; Lee, MK; Oh, KW; Seong, YH; Oh, SK; Jang, CG
      Inhibition of baclofen on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity

      PHARMACOLOGICAL RESEARCH
    35. Sotnikova, TD; Gainetdinov, RR; Grekhova, TV; Rayevsky, KS
      Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study)

      PHARMACOLOGICAL RESEARCH
    36. Chen, TY; Duh, SL; Huang, CC; Lin, TB; Kuo, DY
      Evidence for the involvement of dopamine D-1 and D-2 receptors in mediating the decrease of food intake during repeated treatment with amphetamine

      JOURNAL OF BIOMEDICAL SCIENCE
    37. Ezzat, S
      The role of hormones, growth factors and their receptors in pituitary tumorigenesis

      BRAIN PATHOLOGY
    38. Lee, JI; Shin, HJ; Nam, DH; Kim, JS; Hong, SC; Shin, HJ; Park, K; Eoh, W; Kim, JH; Lee, WY
      Increased burst firing in substantia nigra pars reticulata neurons and enhanced response to selective D2 agonist in hemiparkinsonian rats after repeated administration of apomorphine

      JOURNAL OF KOREAN MEDICAL SCIENCE
    39. Ishiwata, K; Kobayashi, T; Kawamura, K; Matsuno, K; Senda, M
      [C-11]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [C-11]SA4503 binding was not by raclopride

      NUCLEAR MEDICINE AND BIOLOGY
    40. Liang, Q; Satyamurthy, N; Barrio, JR; Toyokuni, T; Phelps, MP; Gambhir, SS; Herschman, HR
      Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction

      GENE THERAPY
    41. Yaghoubi, SS; Wu, L; Liang, Q; Toyokuni, T; Barrio, JR; Namavari, M; Satyamurthy, N; Phelps, ME; Herschman, HR; Gambhir, SS
      Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors

      GENE THERAPY
    42. Rommelspacher, H
      Unravelling genetic modifiers of anxiety and depressiveness in psychiatricdisorders

      PHARMACOGENETICS
    43. Robinet, EA; Wurch, T; Pauwels, PJ
      Different regulation of RGS2 mRNA by haloperidol and clozapine

      NEUROREPORT
    44. Mercier, D; Falardeau, P; Levesque, D
      Autoreceptor preference of dopamine D-2 receptor agonist correlates with preferential coupling to cyclic AMP

      NEUROREPORT
    45. Vukhac, KL; Sankoorikal, EB; Wang, YY
      Dopamine D2L receptor- and age-related reduction in offensive aggression

      NEUROREPORT
    46. Belzung, C; Le Guisquet, AM; Barreau, S; Calatayud, F
      An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice

      BEHAVIOURAL PHARMACOLOGY
    47. Dziedzicka-Wasylewska, M; Ferrari, F; Johnson, RD; Mierau, J; Rogoz, Z; Skuza, G; Sokoloff, P
      Mechanisms of action of pramipexole: Effects on receptors

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    48. Becker, PM; Corrigan, MH; Kasper, S; Lin, SC; Montplaisir, J; Szegedi, A; Willner, P
      Clinical efficacy of pramipexole in the treatment of conditions other thanParkinson's disease

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    49. Armer, JA; Martin, WRW; Pogarell, O
      Tolerability and safety profile of pramipexole in the treatment of Parkinson's disease

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    50. Collier, DA; Osborne, S; Munro, J; Kerwin, RW
      Pharmacogenetic methods in schizophrenia

      INTERNATIONAL REVIEW OF PSYCHIATRY
    51. Malhotra, AK
      The genetics of schizophrenia

      CURRENT OPINION IN PSYCHIATRY
    52. Misztal, T; Romanowicz, K; Barcikowski, B
      Short-term modulation of prolactin secretion by melatonin in anestrous ewes following dopamine- and opiate receptor blockade

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    53. Gomes, I; Jordan, BA; Gupta, A; Rios, C; Trapaidze, N; Devi, LA
      G protein coupled receptor dimerization: implications in modulating receptor function

      JOURNAL OF MOLECULAR MEDICINE-JMM
    54. Ikegami, H; Shishido, T; Ishida, K; Hanada, T; Nakayama, H; Doi, K
      Histopathological and immunohistochemical studies on arteritis induced by fenoldopam, a vasodilator, in rats

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    55. Serretti, A; Rietschel, M; Lattuada, E; Krauss, H; Schulze, TG; Muller, DJ; Maier, W; Smeraldi, E
      Major psychoses symptomatology: factor analysis of 2241 psychotic subjects

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    56. Bernardo, M; Parellada, E; Lomena, F; Catafau, AM; Font, M; Gomez, JC; Lopez-Carrero, C; Gutierrez, F; Pavia, J; Salamero, M
      Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint [I-123]IBZM SPECT study

      PSYCHIATRY RESEARCH-NEUROIMAGING
    57. Lesch, KP
      Variation of serotonergic gene expression: neurodevelopment and the complexity of response to psychopharmacologic drugs

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    58. Virgos, C; Martorell, L; Valero, J; Figuera, L; Civeira, F; Joven, J; Labad, A; Vilella, E
      Association study of schizophrenia with polymorphisms at six candidate genes

      SCHIZOPHRENIA RESEARCH
    59. Dubertret, C; Gorwood, P; Gouya, L; Deybach, JC; Ades, J
      Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients.

      SCHIZOPHRENIA RESEARCH
    60. Clifford, JJ; Kinsella, A; Tighe, O; Rubinstein, M; Grandy, DK; Low, MJ; Croke, DT; Waddington, JL
      Comparative, topographically-based evaluation of behavioural phenotype andspecification of D-1-like: D-2 interactions in a line of incipient congenic mice with D-2 dopamine receptor "knockout"

      NEUROPSYCHOPHARMACOLOGY
    61. Ouagazzal, AM; Grottick, AJ; Moreau, JL; Higgins, GA
      Effect of LSD on prepulse inhibition and spontaneous behavior in the rat: A pharmacological analysis and comparison between two rat strains

      NEUROPSYCHOPHARMACOLOGY
    62. Moy, SS; Knapp, DJ; Breese, GR
      Effect of olanzapine on functional responses from sensitized D-1-dopamine receptors in rats with neonatal dopamine loss

      NEUROPSYCHOPHARMACOLOGY
    63. Martinez, D; Gelernter, J; Abi-Dargham, A; van Dyck, CH; Kegeles, L; Innis, RB; Laruelle, M
      The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporterphenotype in humans

      NEUROPSYCHOPHARMACOLOGY
    64. Betancur, C; Lepee-Lorgeoux, I; Cazillis, M; Accili, D; Fuchs, S; Rostene, W
      Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D-3 receptor deficient mice

      NEUROPSYCHOPHARMACOLOGY
    65. Dassesse, D; Ledent, C; Parmentier, M; Schiffmann, SN
      Acute and chronic caffeine administration differentially alters striatal gene expression in wild-type and adenosine A(2A) receptor-deficient mice

      SYNAPSE
    66. Suzuki, M; Hatano, K; Sakiyama, Y; Kawasumi, Y; Kato, T; Ito, K
      Age-related changes of dopamine D-1-like and D-2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography

      SYNAPSE
    67. Okauchi, T; Suhara, T; Maeda, J; Kawabe, K; Obayashi, S; Suzuki, K
      Effect of endogenous dopamine on extrastriatal [C-11]FLB 457 binding measured by PET

      SYNAPSE
    68. Joyce, JN
      D-2 but not D-3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: Influence of withdrawal period

      SYNAPSE
    69. Ni, ZG; Bouali-Benazzouz, R; Gao, DM; Benabid, AL; Benazzouz, A
      Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat

      SYNAPSE
    70. Garcia-Sanz, A; Badia, A; Clos, MV
      Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [H-3]-dopamine efflux from rat striatal synaptosomes

      SYNAPSE
    71. Muriel, MP; Agid, Y; Hirsch, E
      Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease

      MOVEMENT DISORDERS
    72. Grimes, DA; Bulman, D; St George-Hyslop, P; Lang, AE
      Inherited myoclonus-dystonia: Evidence supporting genetic heterogeneity

      MOVEMENT DISORDERS
    73. Sery, O; Vojtova, V; Zvolsky, P
      The association study of DRD2, ACE and AGT gene polymorphisms and metamphetamine dependence

      PHYSIOLOGICAL RESEARCH
    74. Shearman, LP; Weaver, DR
      Distinct pharmacological mechanisms leading to c-fos gene expression in the fetal suprachiasmatic nucleus

      JOURNAL OF BIOLOGICAL RHYTHMS
    75. Ohngemach, S; Feldkaemper, M; Schaeffel, F
      Pineal control of the dopamine D-2-receptor gene and dopamine release in the retina of the chicken and their possible relation to growth rhythms of the eye

      JOURNAL OF PINEAL RESEARCH
    76. Madrid, GA; MacMurray, J; Lee, JW; Anderson, BA; Comings, DE
      Stress as a mediating factor in the association between the DRD2 TaqI polymorphism and alcoholism

      ALCOHOL
    77. Bau, CHD; Spode, A; Ponso, AC; Elias, EP; Garcia, CED; Costa, FT; Hutz, MH
      Heterogeneity in early onset alcoholism suggests a third group of alcoholics

      ALCOHOL
    78. Ahlskog, JE
      Parkinson's disease: Medical and surgical treatment

      NEUROLOGIC CLINICS
    79. Markianos, M; Lykouras, L; Moussas, G; Hatzimanolis, J
      Changes in dopamine receptor responsivity during alcohol detoxification may predict relapse

      DRUG AND ALCOHOL DEPENDENCE
    80. Csende, F
      A simple procedure for synthesis of roxindole, a dopamine D-2-receptor agonist

      ARCHIV DER PHARMAZIE
    81. Saito, O; Ando, Y; Kusano, E; Asano, Y
      Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    82. Prante, O; Lober, S; Hubner, H; Gmeiner, P; Kuwert, T
      Synthesis and in vitro evaluation of iodine labelled pyrazolo[1,5-a]pyridines as highly selective dopamine D4 receptor ligands

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    83. Rana, BK; Shiina, T; Insel, PA
      Genetic variations and polymorphisms of G protein-coupled receptors: Functional and therapeutic implications

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    84. Smith, R; Musleh, W; Akopian, G; Buckwalter, G; Walsh, JP
      Regional differences in the expression of corticostriatal synaptic plasticity

      NEUROSCIENCE
    85. Adams, DH; Hanson, GR; Keefe, KA
      Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum

      NEUROSCIENCE
    86. Seeger, G; Schloss, P; Schmidt, MH
      Marker gene polymorphisms in hyperkinetic disorder - predictors of clinical response to treatment with methylphenidate?

      NEUROSCIENCE LETTERS
    87. Wang, J; Liu, ZL; Chen, B
      Dopamine D5 receptor gene polymorphism and the risk of levodopa-induced motor fluctuations in patients with Parkinson's disease

      NEUROSCIENCE LETTERS
    88. Robinet, EA; Geurts, M; Maloteaux, JM; Pauwels, PJ
      Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNA

      NEUROSCIENCE LETTERS
    89. Levant, B; McCarson, KE
      D-3 dopamine receptors in rat spinal cord: implications for sensory and motor function

      NEUROSCIENCE LETTERS
    90. Yasuno, F; Suhara, T; Sudo, Y; Yamamoto, M; Inoue, M; Okubo, Y; Suzuki, K
      Relation among dopamine D-2 receptor binding, obesity and personality in normal human subjects

      NEUROSCIENCE LETTERS
    91. Liao, DL; Yeh, YC; Chen, HM; Chen, H; Hong, CJ; Tsai, SJ
      Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

      NEUROPSYCHOBIOLOGY
    92. Bullock, CM; Li, C; Li, M; Bermak, JC; Zhou, QY
      Sensitization of adenylate cyclase induced by a dopamine D2 receptor mutant: Inverse agonism by D2 receptor antagonists

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    93. Waddington, JL; Clifford, JJ; McNamara, FN; Tomiyama, K; Koshikawa, N; Croke, DT
      The psychopharmacology-molecular biology interface: Exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout')

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    94. Tella, SR; Goldberg, SR
      Subtle differences in the discriminative stimulus effects of cocaine and GBR-12909

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    95. Sethi, KD
      Movement disorders induced by dopamine blocking agents

      SEMINARS IN NEUROLOGY
    96. de la Fuente-Fernandez, R; Lim, AS; Sossi, V; Holden, JE; Calne, DB; Ruth, TJ; Stoessl, AJ
      Apomorphine-induced changes in synaptic dopamine levels: Positron emissiontomography evidence for presynaptic inhibition

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    97. Centonze, D; Pisani, A; Bonsi, P; Giacomini, P; Bernardi, G; Calabresi, P
      Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation

      JOURNAL OF NEUROSCIENCE
    98. Zhen, XC; Torres, C; Wang, HY; Friedman, E
      Prenatal exposure to cocaine disrupts D-1A dopamine receptor function via selective inhibition of protein phosphatase 1 pathway in rabbit frontal cortex

      JOURNAL OF NEUROSCIENCE
    99. King, MA; Bradshaw, S; Chang, AH; Pintar, JE; Pasternak, GW
      Potentiation of opioid analgesia in dopamine(2) receptor knock-out mice: Evidence for a tonically active anti-opioid system

      JOURNAL OF NEUROSCIENCE
    100. Dunah, AW; Standaert, DG
      Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane

      JOURNAL OF NEUROSCIENCE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 22:46:37